The unique redox chemistry of metals facilitates a range of neurological functions, including signal transduction, energy production and neurotransmitter synthesis. In a number of major neurodegenerative diseases, dyshomeostasis of these metals have been both implicated in disease pathogenesis and identified as potential novel targets for therapeutic intervention1. To better understand how metals are involved in conditions such as Alzheimer's and Parkinson's disease (AD and PD, respectively), it is imperative to be able to measure how metal distribution and levels change within regions adversely affected by the disease process. These changes are often indicative of subtle shifts in the biochemical reactions that may be intimately linked to the processes that initiate cell death, such as our recently proposed mechanism of iron and dopamine neurotoxicity in PD2.
Traditionally, metal levels within defined anatomical regions has been achieved through careful excision, digestion and analysis using a range of analytical techniques3. However, such an approach loses spatial information, which can be critical when disease states being investigated involve small, well-defined regions or specific cell types. A number of analytical methods are available for visualizing metals in biological systems, from intact samples to tissue sections and in two and three dimensions, using emission spectroscopy, fluorescent probes and mass spectrometry4. Each technique has advantages and disadvantages regarding sensitivity, selectivity of chemical species, and the spatial resolution that can be achieved. For a comprehensive overview of the range of techniques available, see the review by Hare et al.5.
Mass spectrometry (MS)-based methods are the most sensitive of these techniques, capable of measuring most biologically relevant metals at their native concentration6. Laser ablation - inductively coupled plasma - mass spectrometry (LA-ICP-MS) imaging employs a focused ultraviolet laser beam ranging in size from 1 to >100 µm in diameter (or width, when a quadrilateral beam shape is used), under which the sample is passed7. Quantitative information can be achieved through the representative ablation of standard reference materials, which can be produced using a variety of differing approaches8, each with varying degrees of technical difficulty and analytical practicality. The most common approach uses matrix-matching, where a standard with a predominant chemical makeup comparable to that of the sample is prepared by spiking with the target analyte and accurately assessed for homogeneity and absolute metal concentration by independent analytical means9,10. Ablation of prepared standards can then be used for external calibration purposes, allowing concentration data from the resultant sample image to be extracted per pixel.
Image resolution is determined by both the beam size and speed at which the sample is scanned. The standard quadrupole-design ICP-MS (which account for over 90% of all installed ICP-MS systems worldwide11) is a sequential mass analyzer, in that the mass detector cycles through all selected mass-to-charge ratio (m/z) rather than collecting data simultaneously. Thus, the acquisition time for each cycle of masses must equate to the time taken for the sample to traverse one width of the laser beam to ensure a pixel representative of the desired resolution is acquired12. Laser beam size selection is a crucial parameter that has significant effects on both sensitivity and total analysis time. As laser ablation physically removes material that is swept to the ICP-MS by an argon carrier gas, the amount of matter that can be physically detected by the mass analyzer follows the inverse square law. For example, reducing the laser beam diameter from 50 - 25 µm results in a reduction of ablated material by a factor of four. Additionally, as a scanning method, smaller beam diameters increase the total time required to ablate a selected area. Therefore, experimental design is essential to balance the necessary spatial resolution with sensitivity needs and time constraints.
Imaging by LA-ICP-MS has been applied to a range of samples, matrices and disease states, including animal models of neurological disorders13,14, traumatic brain injury15, distribution of metal-containing anticancer drugs16, toxicant exposure in the placenta17 and metal distribution in teeth as a biomarker of early-life dietary transitions.18 In this protocol we describe a general method for imaging iron, copper and zinc in the WT mouse brain at a resolution of 30 µm, though it can be easily adapted to a range of sample types and experimental outcomes, based on the needs of the analyst.